# Jiangxi Fushine Pharmaceutical Co., Ltd. – FDA Inspection, Aug 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/jiangxi-fushine-pharmaceutical-co-ltd/4646763e-feb9-4289-928d-ce7df0e4a3ed
Source feed: FDA_Inspections

> FDA inspection 1280551 of Jiangxi Fushine Pharmaceutical Co., Ltd., August 14, 2025. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1280551
- Company Name: Jiangxi Fushine Pharmaceutical Co., Ltd.
- Inspection Date: 2025-08-14
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- FDA Inspection 1084105 - 2019-01-18
- FDA Inspection 892989 - 2014-07-04

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kham-phommachanh/cc7e728e-d2a1-469d-be3a-4f5fdd43b2dc)
- [Sara H. Gabel](https://www.keypedia.com/people/sara-h-gabel/cd0cd510-ef95-4322-a766-503c994c1f64)

Company: https://www.keypedia.com/companies/jiangxi-fushine-pharmaceutical-co-ltd/f0251298-6a25-4056-b1e7-2db2b106b608

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8